Jenphar Bangladesh Ltd

Jenphar Bangladesh Limited (JBL), a subsidiary of Radiant Pharmaceuticals Ltd., has established itself as a prominent presence in the pharmaceutical industry. Jenphar has its legacy from Julphar Bangladesh Ltd, as a subsidiary of Julphar UAE, one of the largest pharmaceutical manufacturers in the Middle East and Africa. In a strategic move to expand its life-saving drug business, Radiant assimilated Julphar Bangladesh Ltd into Radiant Business Consortium Ltd on July 13, 2020, and subsequently renamed it Jenphar Bangladesh Ltd on Sept 29, 2021. The state-of-the-art manufacturing facilities of JBL has been engineered to comply international regulatory requirements like WHO-GMP, US-FDA & Australian-TGA guidelines. Its product portfolio encompasses over 100 registered products, including Antibiotics, Anti-ulcerants, Pain killers, Anti-hypertensive, Anti-diabetics, Anti-asthmatic, Dermatological and Nutritional supplements. Spanning across 5.4 acres of landscaped, the manufacturing plant...